05/03/2026
Challenges of GLP medications. From 2025 to 2026, 12 million people lost coverage for Zepbound and 12 million lost it for Wegovy.
https://www.npr.org/2026/04/22/nx-s1-5794613/health-insurance-wegovy-zepbound?utm_campaign=feed&utm_medium=referral&utm_source=later-linkinbio&fbclid=PAVERFWARfLJ5leHRuA2FlbQIxMQBzcnRjBmFwcF9pZA8xMjQwMjQ1NzQyODc0MTQAAaenQuz5YzkngbCrYY3S96Zgsm7bIgDVTd0IyaObtcxzc9X-JCrEo1XSvsnxLA_aem_BCnoYkSkGinnXHfwH6Zp1w
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.